In Support of the Priority Review Voucher for Neglected Tropical Diseases
I'm tired of the Priority Review Voucher (PRV)-bashing. For those unaware of the PRV program, it is a new bipartisan incentive mechanism passed by Congress and signed into law in September of 2007. The legislation rewards the sponsor of a neglected tropical disease product with a tradable voucher upon its FDA approval. The voucher can then be used to obtain a priority (speedier) review for another product.